Cost-effectiveness of a stepped care intervention to prevent depression and anxiety in late life: randomised trial.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 20357310.
- Also identified by DOI 10.1192/bjp.bp.109.069617.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is an urgent need for the development of cost-effective preventive strategies to reduce the onset of mental disorders. To establish the cost-effectiveness of a stepped care preventive intervention for depression and anxiety disorders in older people at high risk of these conditions, compared with routine primary care. An economic evaluation was conducted alongside a pragmatic randomised controlled trial (ISRCTN26474556). Consenting individuals presenting with subthreshold levels of depressive or anxiety symptoms were randomly assigned to a preventive stepped care programme (n = 86) or to routine primary care (n = 84). The intervention was successful in halving the incidence rate of depression and anxiety at euro563 ( pound412) per recipient and euro4367 ( pound3196) per disorder-free year gained, compared with routine primary care. The latter would represent good value for money if the willingness to pay for a disorder-free year is at least euro5000. The prevention programme generated depression- and anxiety-free survival years in the older population at affordable cost.
Medical subject headings
- Anxiety Disorders
- Community Mental Health Services
- Depressive Disorder